1 study found for:    sorafenib AND ovarian cancer | Open Studies
Show Display Options
Rank Status Study
1 Unknown  Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Sorafenib

Indicates status has not been verified in more than two years